Abrdn Healthcare Investors (HQH)
| Market Value | 897.07M |
| Revenue (ttm) | 9.97M |
| Net Income (ttm) | 72.87M |
| Shares Out | 50.62M |
| EPS (ttm) | 1.44 |
| PE Ratio | 12.31 |
| Forward PE | n/a |
| Dividend | $2.36 (13.32%) |
| Ex-Dividend Date | Aug 23, 2024 |
| Volume | 175,299 |
| Open | 17.70 |
| Previous Close | 17.63 |
| Day's Range | 17.62 - 17.79 |
| 52-Week Range | 14.58 - 19.79 |
| Beta | 0.74 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About HQH
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recog... [Read more]
News
Worried About A Recession? Income Solutions With Yields Up To 13%
Time in the market trumps timing the market, but the timing of your retirement matters. In retirement, you need a portfolio capable of providing reliable income and mitigating sequence of return risk....
HQH: High Yielding Exposure To Biotech With Positive Outlook
abrdn Healthcare Investors operates as a closed end fund that aims to provide total returns comprised of high current income. HQH offers a high-yielding dividend rate of 12.7% and distributions are pa...
Retire With Dividends: 2 Picks With Yields Up To 12%
The prospects of a failed retirement are only heightened by a recession at the start of your retirement. Change the fuel behind your retirement finances with dividends vs. capital withdrawals. Unlock ...
HQH: Discount Remains Attractive With A Now Higher Distribution Rate
The healthcare sector is traditionally defensive during economic downturns, but not all industries within the healthcare sector are created equal. abrdn Healthcare Investors Fund focuses on the more c...
HQH: Double-Digit Discount And Dividend Ready For Biotech Rally
HQH features a deep NAV discount at 11%, it is cheap and offers good opportunity for price appreciation. Biotech sector is showing strength in recent market rally. HQH with high yield at 13% is a good...
Make Money While You Sleep, 2 Big Dividends For A Retirement Dream
What is your dream retirement? Make goals to achieve it. Don't make monetary number goals that can't answer the "what then?" question. I meet expenses head-on with highly valuable income.
abrdn U.S. Closed-End Funds Announce Results of Annual Meeting of Shareholders
PHILADELPHIA, PA / ACCESSWIRE / June 26, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:HQH)(NYSE:THQ)(NYSE:THW) announced they each held their Annual Meeting of Shareholders (the "Meetings") ...
2 Magnificent Funds To Generate Passive Income
$7.1 trillion is invested in passive ETFs, rocking the market with their inflows and outflows. Few passive ETFs help you achieve specific goals. We look for options to meet our income needs for a life...
HQH: Future Rate Cuts Will Help Fund's Performance
Healthcare sector's performance lags behind S&P 500 due to high interest rates, regulatory uncertainty, and decreased capital expenditure in the sector.
abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce an Additional 20% Increase in Distribution Rates Representing a 50% Increase Since January 2024
PHILADELPHIA, PA / ACCESSWIRE / May 9, 2024 / abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH), (collectively, the "Funds") each, a closed-end management investment company, an...
Buy These 2 Picks If Nothing Else In May
April showers are over, it is time to focus on our top picks for May. Enjoy the warmer weather, improve your health, and improve your portfolio's exposure to the healthcare sector. We look at two outs...
5 Cheap Dividend Funds Trading For Pennies On The Dollar
As contrarians, we search for income stocks that vanilla investors hate. Today there are not many dividend deals left.
The 'Undercovered' Dozen From March 2024
Introducing a new recurring series to help you sift through ideas and data on the site: The "Undercovered" Dozen. In this monthly series, we'll cover twelve ideas from the previous month on stocks tha...
abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update
PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Health...
I Am Loading Up On 2 Bargain Fat Dividends
I can pay my bills in retirement with cash, and I get that cash from picks like these. Your retirement is going to cost you, so have a way to pay for it. Healthcare and Business Development Companies ...
HQH: Healthcare Fund With 11% Income And A High Discount
abrdn Healthcare Investors is a healthcare sector-specific closed-end fund that invests in a portfolio of common stocks in the healthcare industry, heavily weighted in biotechnology. The HQH CEF curre...
How To Invest In A SWAN Portfolio: The Near Perfect Portfolio Strategy
The Near Perfect Portfolio Strategy provides SWAN-like attributes and aims to meet income and growth goals while minimizing volatility and drawdowns. The strategy consists of three buckets: Dividend G...
abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in Distribution Rate
PHILADELPHIA, PA / ACCESSWIRE / February 9, 2024 / abrdn Life Sciences Investors (HQL), abrdn Healthcare Investors (HQH), and abrdn Healthcare Opportunities Fund (THQ) (collectively, the "Funds") each...
HQH: Disappointing Track Record
The abrdn Healthcare Investors (HQH) fund has a 36-year track record of underperforming peers that does not create confidence for future results. HQH focuses on mid and large-cap biotech and pharmaceu...
I Am Bottom Fishing: 2 Great Dividends +9%
The market is not efficient and it is driven by a few select names. I strongly believe that income is the answer to your expenses. True financial freedom is income overwhelming expenses.
The 8% Income Portfolio: 2023 Year-End Review
2023 year-end review of our 8% Income Portfolio. This high-income portfolio earned over $29,000 in distributions amounting to over 14% yield-on-cost basis and roughly 8.6% on average portfolio value. ...
5 Closed-End Fund Buys In The Month Of December 2023 (Plus 1 Sell)
Equity and fixed-income markets had another strong month in December, driven by continuing retreating risk-free Treasury rates. We even saw an improvement in the breadth of the overall market, with br...
Equity CEFs/ETFs: Top Picks For 2024 - Part II
In Part I of my Top Picks For 2024, I explained why we saw such extreme valuation losses in most equity CEFs in 2023 and what that could-mean for 2024. In my opinion, liquidity was the over-riding fac...
HQH: Remains Beaten Down But Also Remains An Interesting Prospect
abrdn Healthcare Investors continues to face pressure as healthcare and biotech sectors remain out of favor. HQH remains an attractive buy if one believes that the healthcare and biotech space can reb...
HQH: I Am Getting A 9.5% Yield On My Last Buy
How's the colder weather treating you? Fighting a cold? I get paid by the healthcare sector, and every year, I'm reminded why exposure to this sector is a must. Let the doctors and big pharma pay for ...